← Leaderboards
M Charlton
Mayo Clinic Coll Of Medicine, Rochester
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Vijay H Shah$27,167,769
- W. Ray Kim$11,120,452
- Mark A. Mc Niven$26,441,783
- Lewis R Roberts$8,981,499
- Robert A. Rizza$75,563,326
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHepatitisHuman Therapy EvaluationLiver CirrhosisLiver MetabolismLiver TransplantationProtein MetabolismApolipoprotein BVery Low Density LipoproteinBlood Lipoprotein Biosynthesis
Grant awards (6)
EFFECT OF CIRRHOSIS ON PROTEIN METABOLISM$0
M01 · FY2002 · RR
VLDL APO-B-100 SYNTHESIS IN NON-ALCOHOLIC STEATOHEPATITIS$0
M01 · FY2002 · RR
EFFECT OF CIRRHOSIS ON PROTEIN METABOLISM$0
M01 · FY2001 · RR
VLDL APO-B-100 SYNTHESIS IN NON-ALCOHOLIC STEATOHEPATITIS$0
M01 · FY2001 · RR
EFFECT OF CIRRHOSIS ON PROTEIN METABOLISM$0
M01 · FY2000 · RR
VLDL APO-B-100 SYNTHESIS IN NON-ALCOHOLIC STEATOHEPATITIS$0
M01 · FY2000 · RR